USANA Health Sciences, Inc. (USNA) |
| 15.06 -0.48 (-3.09%) 10-19 14:53 |
| Open: | 15.56 |
| High: | 15.62 |
| Low: | 15.05 |
| Volume: | 59,442 |
| Market Cap: | 278(M) |
| PE Ratio: | 15.21 |
| Exchange: | New York Stock Exchange |
| Industry: | Packaged Foods |
| Sector: | Consumer Defensive |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 18.68 |
| Resistance 1: | 15.99 |
| Pivot price: | 14.92 |
| Support 1: | 14.76 |
| Support 2: | 14.00 |
| 52w High: | 23.59 |
| 52w Low: | 12.57 |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
| EPS | -1.200 |
| Book Value | 28.510 |
| PEG Ratio | 0.69 |
| Gross Profit | 38.277 |
| Profit Margin (%) | -2.43 |
| Operating Margin (%) | 4.09 |
| Return on Assets (ttm) | 3.6 |
| Return on Equity (ttm) | -5.1 |
Sun, 18 Oct 2026
USANA schedules third-quarter results for USANA Health Sciences stock - ad-hoc-news.de
Mon, 12 Oct 2026
USANA Schedules Third Quarter 2026 Earnings Release and Conference Call - Business Wire
Sat, 10 Oct 2026
How Usana Health Sciences Inc. (USNA) Affects Rotational Strategy Timing - Stock Traders Daily
Wed, 07 Oct 2026
USANA Health Sciences (NYSE:USNA) Upgraded at Zacks Research - MarketBeat
Tue, 06 Oct 2026
USANA Health Sciences (NYSE:USNA) Stock Price - Simply Wall Street
Mon, 05 Oct 2026
The annual general asset-sale limit rises to $2.5M in book value under USANA (USNA)'s credit amendment. - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |